Identification of genetic changes associated with drug resistance by reverse in situ hybridization
Open Access
- 1 January 1997
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 75 (2) , 275-282
- https://doi.org/10.1038/bjc.1997.45
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Integration of the Cytogenetic, Genetic, and Physical Maps of the Human Genome by FISH Mapping of CEPH YAC ClonesGenomics, 1996
- Characterization of Extensive Genetic Alterations in Ductal Carcinoma In Situ by Fluorescence In Situ Hybridization and Molecular AnalysisJNCI Journal of the National Cancer Institute, 1995
- Resistance‐associated factors in human small‐cell lung‐carcinoma GLC4 sub‐lines with increasing adriamycin resistanceInternational Journal of Cancer, 1995
- Mechanisms of MRP over‐expression in four human lung‐cancer cell lines and analysis of the MRP ampliconInternational Journal of Cancer, 1995
- Topoisomerase InhibitorsDrugs, 1995
- Anthracycline Antibiotics in Cancer TherapyDrugs, 1994
- Co-amplification of erbB2, topoisomerase II α and retinoic acid receptor α genes in breast cancer and allelic loss at topoisomerase I on chromosome 20European Journal Of Cancer, 1993
- Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid TumorsScience, 1992
- DNA topoisomerase-targeting antitumor agents and drug resistanceAnti-Cancer Drugs, 1992
- Mechanism of multidrug resistanceBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1988